There have been many discounted cash flow analyses done, some by forum members, others by brokerage houses and stock analysts. I’m not about to dig them out for you, but I can summarize them by saying that the consensus seems to place a fair present value at about $2.50 per share to closer to $3.00 per share. It depends on how projects which remain as R&D at this stage are valued going forward. The low end estimates generally look only at BTM and derivative products.
There have been many discounted cash flow analyses done, some by...
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.15 |
Change
0.030(1.42%) |
Mkt cap ! $1.484B | |||
| Open | High | Low | Value | Volume |
| $2.11 | $2.18 | $2.10 | $3.648M | 1.697M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 27868 | $2.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.16 | 62450 | 9 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.15 |
Change
0.030 ( 1.05 %) |
||||
| Open | High | Low | Volume | ||
| $2.11 | $2.17 | $2.11 | 448602 | ||
| Last updated 15.59pm 29/05/2024 ? | |||||
| PNV (ASX) Chart |